Gürsoy ALAGÖZ, Erdinc BOZKURT, Selçuk YAYLACI, Mahmut ATUM, İsa YUVACI, Ahmed Bilal GENÇ, Turgay UÇAK

Association of neutrophil / lymphocyte ratio, platelet / lymphocyte ratio and brachial retinal vein occlusion

Aim: In this study, we aimed to measure neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) levels in brachialretinal vein occlusion (BRVO) patients and to determine whether there it could be used as a marker for BRVO. Brachial retinal veinocclusion is a serious disease that causes vision loss and is associated with inflammation.Material and Methods:This retrospective study included 77 patients with BRVO and 69 healthy controls. BRVO was diagnosed withophthalmic examination. Blood samples were obtained from venous blood and serum neutrophil, lymphocyte, and platelet data of allpatients were recorded also, NLR-PLR values were calculated.Results:Significant difference were not found between the BRVO group and control group with the level of white blood cells (WBC) andplatelets (p>0.05). Neutrophil count was significantly increased in BRVOs compared to the controls (4.79±1.89 vs 4.02±1.47, p=0.007).Lymphocyte count was significantly decreased in BRVOs compared to the controls. (2.17±0.76 vs 2.52±1.03, p=0.022) NLR wassignificantly increased in BRVOs compared to the controls. (2.60±2.05 vs 1.74±0.70, p=0.001) Also, PLR was significantly increased inBRVOs compared to the controls. (129.70±68.77 vs 107.96±40.65, p=0.023)Conclusion: In our study we found that NLR and PLR were significantly increased in BRVOs than in controls.

PDF

___

1. Wong TY, Scott IU. Retinal vein occlusion. N Engl J Med 2010;363:2135–44.
2. Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313-9.
3. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429-41.
4. Koizumi H, Ferrara DC, Bruè C, et al. Central retinal vein occlusion case-control study. Am J Ophthalmol 2007;144:858-63.
5. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion the eye disease case-control study group. Arch Ophthalmol 1996;114(5):545–554.
6. Jaulim A, Ahmed B, Khanam T, et al. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina 2013;33(5):901-910.
7. Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam 2013:1-6.
8. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26.
9. Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome Am J Cardiol 2008;102:653-7.
10. Akdag S, Akyol A, Asker M, et al. Platelet-to-lymphocyte ratio may predict the severity of calcific aortic stenosis. Med Sci Monit 2015;21:3395.
11. Azab B, Daoud J, Naeem FB, et al. Neutrophil-toLymphocyte Ratio as a Predictor of Worsening Renal Function in Diabetic Patients (3-Year Follow-Up Study). Ren Fail 2012;34:571-6.
12. 12. Ryu HJ, Lee MK, Lee KH, et al. Mean platelet volume is associated with Behcet’s disease activity. Ann Rheum Dis 2014;73:996.
13. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33:111-31.
14. Neumann FJ, Ott I, Marx N, et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997;17:3399-405.
15. van der Poll T, Büller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622- 17.
16. Ulfhammer E, Larsson P, Karlsson L, et al. TNFα mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NFκB and p38 MAPK dependent. J Thromb Haemost 2006;4:1781-9.
17. Noma H, Funatsu H, Mimura T, et al. Pigment epitheliumderived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp Ophthalmol 2010;248:1559-65.
18. Zahorec R. Ratio of neutrophil to lymphocyte counts rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5- 14.
19. Gokhan S, Ozhasenekler A, Durgun HM, et al. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci 2013;17:653–7.
20. 20. Bhat TM, Afari ME, Garcia LA. Neutrophil lymphocyte ratio in peripheral vascular disease: a review. Expert Rev Cardiovasc Ther 2016;14:871-5.
21. 21. Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol 2015;25(4):343-346.
22. Kurtul A, Yarlioglues M, Murat SN, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction. Am J Cardiol 2014;114:342–7.
23. 23. Azab B, Shah N, Akerman M, et al. Value of platelet/ lymphocyte ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326-34.
24. Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer 2015;136:1234-40.